Business
OptimizeRx Seals Multi-Million Dollar Enterprise Deal for Integrated Platform
ROCHESTER, Mich., Jan. 29, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies
About this update from Optimizerx Corporation
[{"type":"text","content":"ROCHESTER, Mich., Jan. 29, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has sealed its largest ever enterprise deal for 12 months of access to its platform and core set of solutions.\n “We are excited at our client’s receptivity to enterprise engagements with our platform as we have integrated all of our existing and new offerings onto a single platform with touchpoints throughout the care journey,” said OptimizeRx Chief Commerical Officer Steve Silvestro. “This comprehensive solution further lowers the barriers that have prevented providers and healthcare consumers from achieving the best possible care outcomes. Additionally, we are seeing very strong performance results for our clients stemming from improved interoperability between our point-of-care and direct-to-patient communications, all working together to deliver improved outcomes.” The new platform enables unprecedented transparency into patient medication behavior as well as provides access to patient-provider-pharma communication across the care continuum and in a variety of care settings. Pharmaceutical companies, healthcare providers and payers are now better able to efficiently and effectively address patient medication affordability and therapeutic adherence. “As we discussed in the last earnings call,” continued Silvestro, \"we have a strong pipeline of opportunities and this enterprise deal is the first of a few deals we’ll announce which bring us back to the high growth expected from our emerging growth company.” The platform is integrated within the workflows of some of the world’s largest electronic health record (EHR) platforms in ambulatory settings and a growing number of hospitals and health systems. Providers can deliver patient support and relevant brand engagement beyond e-couponing at earlier stages of the patient’s journey to support adherence and better outcomes. Through the platform’s intelligent integration of real-time data and communication, life science companies can align messaging to specific kinds of providers and patient populations, provide greater transparency, and more effectively reach patients at the point-of-care and beyond. OptimizeRx CEO Will Febbo commented: “This is a major milestone for our company and it reflects the increasing int...